Dr. Matthew Austin
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- State University of New York at Buffalo School of Medicine (2014)
- Years since graduation
- 12
- In the NPI registry since
- 2014
- Medicare patients seen, 2024
- 266
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2014Medical school: State University of New York at Buffalo School of Medicine
- 2014Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
RI license MD15821 -
Internal Medicine Physician
RI license MD15821 · RI license LP03110 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Yale-New Haven Hospital New Haven, CT
- The Miriam Hospital Providence, RI
- Lawrence & Memorial Hospital New London, CT
- South County Hospital Inc Wakefield, RI
- Westerly Hospital Westerly, RI
Medical groups
- Northeast Medical Group Inc (1,360 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 266
- Services billed
- 1,441
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 191 | 81 |
| Established patient office or other outpatient visit, 40-54 minutes | 175 | 66 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 58 | 29 |
| New patient office or other outpatient visit, 60-74 minutes | 48 | 48 |
| New patient office or other outpatient visit, 45-59 minutes | 38 | 37 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 35 | 26 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 32 | 31 |
| Established patient office or other outpatient visit, 20-29 minutes | 32 | 24 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 29 | 17 |
| Telephone medical discussion with physician, 21-30 minutes | 23 | 18 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisone Other prescribers in New Haven, CT | 159 |
| Eliquis (apixaban) Other prescribers in New Haven, CT | 111 |
| Abiraterone Acetate | 70 |
| Dexamethasone Other prescribers in New Haven, CT | 44 |
| Erleada (apalutamide) | 40 |
| Prochlorperazine Maleate Other prescribers in New Haven, CT | 38 |
| Lenalidomide | 38 |
| Oxycodone Hcl Other prescribers in New Haven, CT | 33 |
| Acyclovir Other prescribers in New Haven, CT | 31 |
| Ondansetron Odt (ondansetron) Other prescribers in New Haven, CT | 28 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $1,263 in total to this clinician.
| Janssen Biotech, Inc. | $1,263 |
|---|
| Consulting Fee | $1,263 |
|---|
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Sep 12, 2025 | Consulting Fee ERLEADA · Oncology | $1,263 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.